BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 21188498)

  • 21. HLA class II genotyping in chronic hepatitis B infection.
    Amarapurpar DN; Patel ND; Kankonkar SR
    J Assoc Physicians India; 2003 Aug; 51():779-81. PubMed ID: 14651137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Study on the association between severe chronic hepatitis B and HLA-DRB1 gene polymorphism].
    Liang HX; Yu ZJ; Jiang HQ; Zhang XQ
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Oct; 23(5):364-6. PubMed ID: 20387488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutation "hot spot" in HLA class I-restricted T cell epitope on hepatitis B surface antigen in chronic carriers and hepatocellular carcinoma.
    Chen WN; Oon CJ
    Biochem Biophys Res Commun; 1999 Sep; 262(3):757-61. PubMed ID: 10471398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of HLA phenotype with primary non-response to recombinant hepatitis B vaccine: a study from north India.
    Das K; Gupta RK; Kumar V; Singh S; Kar P
    Trop Gastroenterol; 2004; 25(3):113-5. PubMed ID: 15682656
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HLA-A, B, C, DR and DQ expression and hepatocellular carcinoma: study of 205 Italian subjects.
    Ricci G; Colombo C; Ghiazza B; Porta C; Moroni M; Illeni MT
    Cancer Lett; 1995 Nov; 98(1):121-5. PubMed ID: 8529200
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of repeated high-dose hepatitis B vaccine (80 microg) in patients with chronic liver disease.
    Aziz A; Aziz S; Li DS; Murphy L; Leone N; Kennedy M; Dhillon S; Van Thiel DH
    J Viral Hepat; 2006 Apr; 13(4):217-21. PubMed ID: 16611186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis B virus genotype D prevails in patients with persistently elevated or normal ALT levels in Turkey.
    Yalcin K; Degertekin H; Bahcecioglu IH; Demir A; Aladag M; Yildirim B; Horasanli S; Ciftci S; Badur S
    Infection; 2004 Feb; 32(1):24-9. PubMed ID: 15007739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between HLA-DP gene polymorphisms and clearance of chronic hepatitis B virus infections: case-control study and meta-analysis.
    Yan Z; Tan S; Dan Y; Sun X; Deng G; Wang Y
    Infect Genet Evol; 2012 Aug; 12(6):1222-8. PubMed ID: 22543033
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Study on the function of circulating plasmacytoid dendritic cells in the immunoactive phase of patients with chronic genotype B and C HBV infection.
    Wang K; Fan X; Fan Y; Wang B; Han L; Hou Y
    J Viral Hepat; 2007 Apr; 14(4):276-82. PubMed ID: 17381720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis B viral factors and clinical outcomes of chronic hepatitis B.
    Lin CL; Kao JH
    J Biomed Sci; 2008 Mar; 15(2):137-45. PubMed ID: 18058038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complete genome sequence and phylogenetic analysis of hepatitis B virus isolated from Turkish patients with chronic HBV infection.
    Bozdayi G; Türkyilmaz AR; Idilman R; Karatayli E; Rota S; Yurdaydin C; Bozdayi AM
    J Med Virol; 2005 Aug; 76(4):476-81. PubMed ID: 15977237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low frequency of precore mutants in anti-hepatitis B e antigen positive subjects with chronic hepatitis B virus infection in Chennai, Southern India.
    Shanmugam S; Velu V; Nandakumar S; Madhavan V; Shanmugasundaram U; Shankar EM; Murugavel KG; Balakrishnan P; Kumarasamy N; Solomon S; Thyagarajan SP
    J Microbiol Biotechnol; 2008 Oct; 18(10):1722-8. PubMed ID: 18955826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Association of haplotype formed on HLA-DRB1 and HLA-DQA1 alleles with outcomes of hepatitis B virus infection].
    Lu LP; Li XW; Liu Y; Sun GC; Chen ZH; Zhu XL; Hu QY; Li H
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Aug; 23(4):427-30. PubMed ID: 16883532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytokine-dependent anti-viral role of CD4-positive T cells in therapeutic vaccination against chronic hepatitis B viral infection.
    Ren F; Hino K; Yamaguchi Y; Funatsuki K; Hayashi A; Ishiko H; Furutani M; Yamasaki T; Korenaga K; Yamashita S; Konishi T; Okita K
    J Med Virol; 2003 Nov; 71(3):376-84. PubMed ID: 12966542
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Virological and clinical implication of core promoter C1752/V1753 and T1764/G1766 mutations in hepatitis B virus genotype D infection in Mongolia.
    Elkady A; Tanaka Y; Kurbanov F; Oynsuren T; Mizokami M
    J Gastroenterol Hepatol; 2008 Mar; 23(3):474-81. PubMed ID: 18318825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical significance and evolution of core promoter and precore mutations in HBeAg-positive patients with HBV genotype B and C: a longitudinal study.
    Chen CH; Lee CM; Hung CH; Hu TH; Wang JH; Wang JC; Lu SN; Changchien CS
    Liver Int; 2007 Aug; 27(6):806-15. PubMed ID: 17617124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Study on the polymorphisme of human leucocyte antigen-DRB1, -DQA1 and -DQB1 alleles in patients with hepatitis B].
    Jiang YG; Wang YM
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Apr; 25(4):337-40. PubMed ID: 15231205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Seroprevalence of chronic hepatitis B virus infection among taiwanese human immunodeficiency virus type 1-positive persons in the era of nationwide hepatitis B vaccination.
    Sun HY; Ko WC; Tsai JJ; Lee HC; Liu CE; Wong WW; Su SC; Ho MW; Cheng SH; Yang CH; Lin YH; Miao WJ; Sheng WH; Hung CC
    Am J Gastroenterol; 2009 Apr; 104(4):877-84. PubMed ID: 19259078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of concurrent hepatitis B surface antigen and antibody to hepatitis B surface antigen with hepatocellular carcinoma in chronic hepatitis B virus infection.
    Jang JS; Kim HS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Kim DJ; Lee MS; Park CK; Jeong BH; Kim YS; Jang MK
    J Med Virol; 2009 Sep; 81(9):1531-8. PubMed ID: 19623669
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The characteristics of the cell-mediated immune response identify different profiles of occult hepatitis B virus infection.
    Zerbini A; Pilli M; Boni C; Fisicaro P; Penna A; Di Vincenzo P; Giuberti T; Orlandini A; Raffa G; Pollicino T; Raimondo G; Ferrari C; Missale G
    Gastroenterology; 2008 May; 134(5):1470-81. PubMed ID: 18355815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.